Kiniksa Pharmaceuticals
KNSA
#2410
Rank
NZ$13.50 B
Marketcap
๐Ÿ‡ง๐Ÿ‡ฒ
Country
NZ$171.85
Share price
-0.06%
Change (1 day)
135.60%
Change (1 year)

EPS for Kiniksa Pharmaceuticals (KNSA)

EPS in 2026 (TTM): NZ$2.51

According to Kiniksa Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ$2.59. In 2025 the company made an earnings per share (EPS) of NZ$1.45 an increase over its 2024 EPS that were of NZ-$1.10.

EPS history for Kiniksa Pharmaceuticals from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$2.5173.76%
2025NZ$1.45-231.15%
2024NZ-$1.10-421.05%
2023NZ$0.34-92.8%
2022NZ$4.77-214.78%
2021NZ-$4.16-10.85%
2020NZ-$4.66-14.57%
2019NZ-$5.466.33%
2018NZ-$5.14

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ-$2.44-194.41%๐Ÿ‡บ๐Ÿ‡ธ USA